We are a leader and one of the most geographically diverse operators in the theatrical exhibition industry. As of December 31, 2025, we operated 496 theaters and 5,637 screens in the United States, or U.S. , and Latin America.
$28.00
+$0.76 (+2.79%)
Price from 5 days ago
Revenue growth slowed to 2.1%, essentially flat. This is a business that needs a catalyst.
Even for strong businesses, today's 22x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
21.5x earnings. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$3.22B
▲ +2.1% YoY
Net Income (TTM)
$171M
▼ -55.4% YoY
Op. Margin
—
ROIC
—
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow
N/A
Net Debt
$1.12B
Cash & Equiv.
$0.00
5Y CAGR: +35.3%
5Y CAGR: -12.3%
Continue Research